Paolo G Casali Selected Research

Alveolar Soft Part Sarcoma

1/2018	Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
6/2014	Emerging therapies for adult soft tissue sarcoma.
9/2013	Adjuvant therapy for high-risk soft tissue sarcoma in the adult.
2/2009	Response to sunitinib malate in advanced alveolar soft part sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo G Casali Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 02/2004
47	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2003
20	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 01/2003
9	Myxoid Liposarcoma 01/2022 - 07/2007
8	Neoplasm Metastasis (Metastasis) 12/2019 - 08/2004
7	Chordoma 01/2022 - 11/2004
7	Disease Progression 01/2021 - 06/2012
6	Dermatofibrosarcoma 01/2017 - 10/2005
5	Leiomyosarcoma 01/2020 - 07/2010
4	Perivascular Epithelioid Cell Neoplasms 10/2020 - 10/2013
4	Chondrosarcoma 01/2019 - 02/2011
4	Alveolar Soft Part Sarcoma 01/2018 - 02/2009
4	Liposarcoma 05/2016 - 07/2007
4	Synovial Sarcoma (Synovioma) 07/2015 - 02/2004
4	Extraskeletal Myxoid Chondrosarcoma 06/2014 - 10/2012
3	Hypertension (High Blood Pressure) 01/2019 - 05/2012
3	Clear Cell Sarcoma 02/2015 - 02/2012
3	Solitary Fibrous Tumors 06/2014 - 05/2010
3	Fatigue 05/2012 - 09/2006
3	Nausea 05/2012 - 09/2006
2	Epithelioid Hemangioendothelioma 01/2021 - 01/2016
2	Cardiotoxicity 01/2020 - 04/2007
2	Melanoma (Melanoma, Malignant) 02/2015 - 02/2012
2	Fibrosarcoma 06/2014 - 10/2011
2	Genetic Translocation (Chromosomal Translocation) 11/2012 - 07/2007
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Necrosis 01/2022
1	Menstruation Disturbances 01/2021
1	Rupture 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2020
1	Osteolysis 01/2020
1	Infections 03/2019
1	Sepsis (Septicemia) 03/2019
1	Neutropenia 01/2019
1	Mucositis 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Soft Tissue Neoplasms 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2016
1	Hemangiopericytoma 07/2016
1	Hemangioendothelioma 01/2016

Drug/Important Bio-Agent (IBA)

31	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2004
12	TrabectedinIBA 01/2022 - 07/2007
9	Ifosfamide FDA LinkGeneric 01/2022 - 01/2015
9	Tyrosine Kinase InhibitorsIBA 08/2019 - 07/2004
8	AnthracyclinesIBA 12/2021 - 12/2013
8	Sunitinib (Sutent)FDA Link 02/2015 - 09/2007
6	Biological ProductsIBA 01/2019 - 08/2009
5	Gemcitabine FDA Link 01/2020 - 06/2014
5	pazopanib FDA Link 01/2020 - 05/2012
5	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2015 - 11/2004
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2011 - 02/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 12/2006
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2007
4	Phosphotransferases (Kinase)IBA 10/2012 - 02/2004
3	nilotinib FDA Link 12/2021 - 09/2009
3	MTOR InhibitorsIBA 10/2020 - 08/2010
3	TOR Serine-Threonine KinasesIBA 10/2018 - 07/2013
2	multidrug resistance-associated protein 1IBA 12/2021 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2012
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 11/2015
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 11/2015 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 11/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 02/2004
2	LigandsIBA 08/2010 - 02/2004
2	Dihydrotachysterol (AT 10)IBA 06/2007 - 10/2005
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	mifamurtideIBA 01/2022
1	Brachyury protein (Brachyury)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	avapritinibIBA 12/2021
1	ripretinibIBA 12/2021
1	AZD 6244IBA 12/2021
1	Transcriptional Coactivator with PDZ-Binding Motif ProteinsIBA 01/2021
1	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2020
1	exemestane (Aromasin)FDA Link 10/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Denosumab FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	BilirubinIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Semaphorins (Semaphorin)IBA 01/2019
1	Everolimus FDA Link 10/2018
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2016

Therapy/Procedure

24	Therapeutics 01/2021 - 11/2004
23	Drug Therapy (Chemotherapy) 01/2020 - 01/2003
10	Radiotherapy 03/2019 - 01/2007
5	Adjuvant Chemotherapy 01/2019 - 08/2004
3	Molecular Targeted Therapy 10/2005 - 11/2004
2	Catheters 03/2019 - 09/2016
2	Neoadjuvant Therapy 07/2017 - 09/2013
1	Laparotomy 10/2019
1	Immunotherapy 01/2017
1	Prostheses and Implants (Prosthesis) 09/2016
1	Embolectomy 09/2016